Occidental Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $499K | Buy |
8,230
+544
| +7% | +$31.7K | 0.06% | 163 |
|
|
2025
Q4 | $415K | Sell |
7,686
-741
| -9% | -$35.6K | 0.05% | 174 |
|
|
2025
Q3 | $380K | Buy |
8,427
+29
| +0.3% | +$1.35K | 0.05% | 182 |
|
|
2025
Q2 | $389K | Sell |
8,398
-35
| -0.4% | -$1.72K | 0.05% | 170 |
|
|
2025
Q1 | $514K | Sell |
8,433
-1,596
| -16% | -$93K | 0.08% | 134 |
|
|
2024
Q4 | $567K | Buy |
10,029
+8
| +0.1% | +$447 | 0.09% | 130 |
|
|
2024
Q3 | $518K | Buy |
10,021
+886
| +10% | +$41.6K | 0.08% | 142 |
|
|
2024
Q2 | $379K | Buy |
9,135
+637
| +7% | +$28.5K | 0.07% | 148 |
|
|
2024
Q1 | $461K | Sell |
8,498
-1,380
| -14% | -$70.3K | 0.09% | 137 |
|
|
2023
Q4 | $507K | Sell |
9,878
-193
| -2% | -$10.1K | 0.11% | 136 |
|
|
2023
Q3 | $585K | Sell |
10,071
-1,500
| -13% | -$91.9K | 0.14% | 126 |
|
|
2023
Q2 | $740K | Hold |
11,571
| – | – | 0.17% | 124 |
|
|
2023
Q1 | $802K | Hold |
11,571
| – | – | 0.2% | 114 |
|
|
2022
Q4 | $833K | Buy |
11,571
+1,150
| +11% | +$86.7K | 0.23% | 109 |
|
|
2022
Q3 | $741K | Hold |
10,421
| – | – | 0.22% | 106 |
|
|
2022
Q2 | $802K | Sell |
10,421
-75
| -0.7% | -$5.71K | 0.24% | 105 |
|
|
2022
Q1 | $767K | Hold |
10,496
| – | – | 0.2% | 108 |
|
|
2021
Q4 | $654K | Sell |
10,496
-1,100
| -9% | -$64.5K | 0.16% | 130 |
|
|
2021
Q3 | $686K | Hold |
11,596
| – | – | 0.18% | 124 |
|
|
2021
Q2 | $775K | Sell |
11,596
-248
| -2% | -$16.2K | 0.21% | 115 |
|
|
2021
Q1 | $748K | Sell |
11,844
-13,217
| -53% | -$822K | 0.22% | 111 |
|
|
2020
Q4 | $1.55M | Buy |
25,061
+506
| +2% | +$31.1K | 0.52% | 40 |
|
|
2020
Q3 | $1.48M | Sell |
24,555
-11
| -0% | -$662 | 0.62% | 30 |
|
|
2020
Q2 | $1.44M | Buy |
24,566
+1,864
| +8% | +$111K | 0.64% | 28 |
|
|
2020
Q1 | $1.26M | Buy |
22,702
+12,633
| +125% | +$772K | 0.64% | 28 |
|
|
2019
Q4 | $646K | Buy |
10,069
+150
| +2% | +$8.59K | 0.26% | 99 |
|
|
2019
Q3 | $503K | Sell |
9,919
-100
| -1% | -$4.7K | 0.21% | 104 |
|
|
2019
Q2 | $454K | Hold |
10,019
| – | – | 0.2% | 104 |
|
|
2019
Q1 | $478K | Hold |
10,019
| – | – | 0.23% | 95 |
|
|
2018
Q4 | $521K | Hold |
10,019
| – | – | 0.29% | 65 |
|
|
2018
Q3 | $622K | Hold |
10,019
| – | – | 0.31% | 68 |
|
|
2018
Q2 | $554K | Sell |
10,019
-2,000
| -17% | -$108K | 0.3% | 62 |
|
|
2018
Q1 | $760K | Hold |
12,019
| – | – | 0.41% | 47 |
|
|
2017
Q4 | $737K | Hold |
12,019
| – | – | 0.38% | 48 |
|
|
2017
Q3 | $766K | Hold |
12,019
| – | – | 0.42% | 45 |
|
|
2017
Q2 | $670K | Sell |
12,019
-150
| -1% | -$8.16K | 0.4% | 45 |
|
|
2017
Q1 | $662K | Sell |
12,169
-150
| -1% | -$8.23K | 0.44% | 40 |
|
|
2016
Q4 | $720K | Hold |
12,319
| – | – | 0.52% | 44 |
|
|
2016
Q3 | $664K | Hold |
12,319
| – | – | 0.54% | 43 |
|
|
2016
Q2 | $906K | Buy |
12,319
+4,019
| +48% | +$284K | 0.79% | 37 |
|
|
2016
Q1 | $530K | Hold |
8,300
| – | – | 0.64% | 38 |
|
|
2015
Q4 | $571K | Sell |
8,300
-100
| -1% | -$6.61K | 0.73% | 31 |
|
|
2015
Q3 | $497K | Hold |
8,400
| – | – | 0.7% | 33 |
|
|
2015
Q2 | $559K | Hold |
8,400
| – | – | 0.75% | 34 |
|
|
2015
Q1 | $542K | Hold |
8,400
| – | – | 0.68% | 33 |
|
|
2014
Q4 | $496K | Sell |
8,400
-900
| -10% | -$50.8K | 0.76% | 36 |
|
|
2014
Q3 | $476K | Hold |
9,300
| – | – | 0.78% | 28 |
|
|
2014
Q2 | $451K | Hold |
9,300
| – | – | 0.77% | 33 |
|
|
2014
Q1 | $483K | Buy |
+9,300
| New | +$495K | 0.86% | 28 |
|
Other funds holding BMY
VCM
VPM
Occidental Asset Management's BMY Position: Q1 2026 in Review
Occidental Asset Management increased its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, buying an estimated $31.7K and bringing the position to 8,230 shares worth $499K. The position accounts for 0.06% of the portfolio, ranked #163.
Occidental Asset Management first reported a position in BMY in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.55M in Q4 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Occidental Asset Management held 8,230 shares of Bristol-Myers Squibb worth $499K as of Q1 2026.
- Occidental Asset Management bought 544 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.7K.
- Bristol-Myers Squibb made up 0.06% of Occidental Asset Management's portfolio in Q1 2026, its #163 holding.
- Occidental Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 49 quarters since.
- Occidental Asset Management's Bristol-Myers Squibb position peaked at $1.55M in Q4 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.